Clinical profile of patients treated with cefepime/tazobactam: A new ß-lactam/ß-lactamase inhibitor combination
Objectives: Cefepime/tazobactam is a new ß-lactam/ß-lactamase inhibitor combination licensed for clinical use byDrugs Controller General of India. Aim of our study was to analyze the clinical efficacy and safety of cefepime/tazobactamin patients with sepsis. To the best of our knowledge, this is the...
Na minha lista:
| Principais autores: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Eldaghayes Publisher
2012-06-01
|
| 叢編: | Journal of Microbiology and Infectious Diseases |
| 主題: | |
| 在線閱讀: | http://www.jcmid.org/upload/sayi/9/JMID-00583.pdf |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|